TRANSTISSUE TECHNOLOGIES GMBH - Germany 

Ranking results:

Past rankings:

2012
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2012-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 5.988.155 340.529 1
2012 0 3.071.055 304.350 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
3D MATRIX EUROPE SAS1
ASOCIACION ESPANOLA DE NORMALIZACION Y CERTIFICACION1
BIOMED CENTER INNOVATION GGMBH1
BIOTECHNOLOGY INSTITUTE I MAS D1
CELLARTIS AB1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CN BIO INNOVATIONS LIMITED1
ELKEM SILICONES FRANCE SAS1
FLUIDINOVA1
JOHANNES KEPLER UNIVERSITAT LINZ1
KEPLER UNIVERSITATSKLINIKUM1
LITHOZ1
LUDWIG BOLTZMANN GESELLSCHAFT OSTERREICHISCHE VEREINIGUNG ZUR FORDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG1
LUXINERGY1
MEDIZINISCHE UNIVERSITAET WIEN1
MICRONIT MICROFLUIDICS B V1
PROFACTOR1
STRATASYS1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
TIGER COATINGS1
UNIVERSIDAD POLITECNICA DE MADRID1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1

Constancy:

Total number of partners: 22
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 22
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-01-01INK-BASED HYBRID MULTI-MATERIAL FABRICATION OF NEXT GENERATION IMPLANTS INKplantparticipant5.988.15519
2012-01-01THE PRODUCTION OF A 3D HUMAN TISSUE DISEASE PLATFORM TO ENABLE REGENERATIVE MEDICINE THERAPY DEVELOPMENT TissueGENparticipant3.071.0555